Nanopath Inc — Form D
Nanopath Inc of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-06. The offering totals $6.0M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-06
- Form: D
- Accession: 0002054472-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.3M
- Remaining: $659K
- Investors: 5
- Date of first sale: 2025-01-24
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-537525
Issuer
- Name: Nanopath Inc
- CIK: 0001940981
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 750 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 617-249-4542
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alison Burklund | Director | Cambridge, MA |
| Jeff Crowe | Director | San Francisco, CA |
| Aaron Sandoski | Director | Bedford, MA |
| Amogha Tadimety | Director | Cambridge, MA |
| Alison Burklund | Executive Officer | Cambridge, MA |
| Amogha Tadimety | Executive Officer | Cambridge, MA |
| Jeffrey Crowe | Director | San Jose, CA |
Other filings by this issuer (1)
More